FGAM
FLGT icon

Financial Gravity Asset Management’s Fulgent Genetics FLGT Stock Holding History

Financial Gravity Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,222
Closed -$3.05K – 944
2021
Q4 		$3.05K Buy
+2,222
New +$195K 0.07% 279
2021
Q3 		– Sell
-41
Closed -$92K – 969
2021
Q2 		$92K Buy
+41
New +$3.27K 0.03% 369

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Gravity Asset Management's FLGT Position: Q1 2022 in Review

Financial Gravity Asset Management sold out of Fulgent Genetics (FLGT) in Q1 2022, closing a stake of 2,222 shares — an estimated $3.05K sold.

Financial Gravity Asset Management first reported a position in FLGT in Q2 2021 and held it in 2 quarters. The position peaked at $92K in Q2 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • Financial Gravity Asset Management reported no remaining Fulgent Genetics position as of Q1 2022 after selling out during the quarter.
  • Financial Gravity Asset Management sold 2,222 Fulgent Genetics shares in Q1 2022, an estimated $3.05K.
  • Financial Gravity Asset Management first reported a position in Fulgent Genetics in Q2 2021 and held it in 2 quarters.
  • Financial Gravity Asset Management's Fulgent Genetics position peaked at $92K in Q2 2021.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on Financial Gravity Asset Management's 13F filing for Q1 2022, filed 13 May 2022.